Skip to Content

Bromfenac ophthalmic Pregnancy and Breastfeeding Warnings

Bromfenac ophthalmic is also known as: Bromday, Prolensa, Xibrom

Bromfenac ophthalmic Pregnancy Warnings

Bromfenac ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity; however, embryo-fetal lethality, increased neonatal mortality, reduced postnatal growth, and increased post-implantation loss have been reported. There are no controlled data in human pregnancy. Bromfenac ophthalmic is only recommended for use during pregnancy when benefit outweighs risk. Because nonsteroidal anti-inflammatory drugs are known to delay parturition or cause premature closure of the ductus arteriosus, bromfenac ophthalmic should be avoided during late pregnancy.

See references

Bromfenac ophthalmic Breastfeeding Warnings

There are no data on the excretion of bromfenac ophthalmic into human milk. The manufacturer recommends caution be used when administering bromfenac ophthalmic to nursing women.

See references

References for pregnancy information

  1. "Product Information. Xibrom (bromfenac ophthalmic)." ISTA Pharmaceuticals, Irvine, CA.

References for breastfeeding information

  1. "Product Information. Xibrom (bromfenac ophthalmic)." ISTA Pharmaceuticals, Irvine, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.